← FDA Drug Approvals (Drugs@FDA)

AFEDITAB CR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2001-10-26

Drug application

FDA Application #

ANDA075659

Application type

Abbreviated New Drug Application (Generic)

Brand name

AFEDITAB CR

Generic name

Nifedipine

Active ingredients

NIFEDIPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS

First approval

2001-10-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown